Publication | Closed Access

Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia:

Hematological MalignancyMedicineHematologyImmunologyPharmacologyAcute Myeloid LeukaemiaPharmacotherapyOncologyMyeloid Neoplasia